MedTrace Logo

Injectable Bulking Agent Needle Guide

NCT00763711 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2012-01-10

No results posted yet for this study

Summary

The purpose of this study is to evaluate the use of the Needle Guide as an assist in properly guiding an injection needle into the appropriate tissue plane during an injectable bulking agent procedure in women using a FDA approved injectable bulking agent. The injectable bulking agent will be Durasphere EXP.

Conditions

Interventions

DEVICE

Needle Guided Periurethral Injection

Bulking Agent injection using a needle guide

Sponsors & Collaborators

  • Carbon Medical Technologies

    lead INDUSTRY

Principal Investigators

  • Dean Klein · Carbon Medical Technologies

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00763711 on ClinicalTrials.gov